Net Cash Provided by (Used in) Financing Activities of XBiotech Inc. from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
XBiotech Inc. annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • XBiotech Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $10,250,000, a 202% decline year-over-year.
  • XBiotech Inc. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $10,250,000, a 198% decline from 2024.
  • XBiotech Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $10,450,000.
  • XBiotech Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $9,000,000.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

XBiotech Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $10,250,000 -$20,700,000 -198% 01 Jan 2025 31 Dec 2025 10-K 13 Mar 2026 2025 FY
2024 $10,450,000 +$19,450,000 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2026 2025 FY
2023 $9,000,000 -$9,000,000 01 Jan 2023 31 Dec 2023 10-K 18 Mar 2025 2024 FY
2022 $0 +$67,008,000 01 Jan 2022 31 Dec 2022 10-K 15 Mar 2024 2023 FY
2021 $67,008,000 +$342,716,000 +84% 01 Jan 2021 31 Dec 2021 10-K 15 Mar 2023 2022 FY
2020 $409,724,000 -$451,820,000 -1073% 01 Jan 2020 31 Dec 2020 10-K 15 Mar 2022 2021 FY
2019 $42,096,000 +$41,895,000 +20843% 01 Jan 2019 31 Dec 2019 10-K 15 Mar 2022 2021 FY
2018 $201,000 -$33,122,000 -99% 01 Jan 2018 31 Dec 2018 10-K 16 Mar 2021 2020 FY
2017 $33,323,000 +$30,379,000 +1032% 01 Jan 2017 31 Dec 2017 10-K 16 Mar 2020 2019 FY
2016 $2,944,000 -$74,526,000 -96% 01 Jan 2016 31 Dec 2016 10-K/A 15 Mar 2019 2018 FY
2015 $77,470,000 +$14,270,000 +23% 01 Jan 2015 31 Dec 2015 10-K 16 Mar 2018 2017 FY
2014 $63,200,000 +$51,155,000 +425% 01 Jan 2014 31 Dec 2014 10-K 16 Mar 2017 2016 FY
2013 $12,045,000 01 Jan 2013 31 Dec 2013 10-K 15 Apr 2016 2015 FY

XBiotech Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $10,250,000 -$20,305,000 -202% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q1 2024 $10,055,000 +$10,055,000 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q1 2023 $0 $0 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q1 2022 $0 -$1,022,000 -100% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q1 2021 $1,022,000 +$413,104,000 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q1 2020 $412,082,000 -$412,823,000 -55712% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q1 2019 $741,000 +$540,000 +269% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q1 2018 $201,000 -$32,512,000 -99% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q1 2017 $32,713,000 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018 2018 Q1
Q1 2015 $2,107,000 -$9,498,000 -82% 01 Jan 2015 31 Mar 2015 10-Q 13 May 2016 2016 Q1
Q1 2014 $11,605,000 01 Jan 2014 31 Mar 2014 10-Q 18 Jun 2015 2015 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.